Biopeak Raises $2.7 Mn to Scale AI-Led Longevity Care

0

Longevity Care Is Moving From Wellness to Clinical Precision

India’s health-tech landscape is seeing a shift from generic wellness programmes to data-driven longevity care. High-performing professionals and families are increasingly seeking early risk detection, personalised interventions, and longitudinal health tracking rather than reactive treatment. This has opened room for clinically anchored platforms that combine diagnostics, AI, and expert-led programmes.

Funding Snapshot

Bengaluru-based health-tech startup Biopeak has raised $2.7 million in a follow-on funding round led by NKSquared, the family office of Nikhil Kamath.
This marks Kamath’s second investment in the company after a $1.43 million infusion in August 2024. The capital will be used to expand clinic operations and strengthen diagnostics, AI tools, research, and clinical programmes.

What Biopeak Is Building

Co-founded in 2025 by Rishi Pardal and Shiva Subramanian, Biopeak positions itself as a “family health office” focused on healthspan optimisation. The platform combines AI-driven molecular diagnostics, advanced imaging, and expert-led programmes to create personalised longevity plans.

Its diagnostics stack integrates organic acid profiling, microbiome mapping, whole-exome functional genomics, salivary cortisol rhythms, and imaging such as MRI, CT, DXA, and ECHO. These insights are translated into actionable guidance across nutrition, sleep, stress, and performance through Biopeak’s in-house clinics.

Growth Strategy and Market Signal

Biopeak targets executives, high achievers, and women, tailoring interventions to Indian biology and disease patterns. Over the past year, it has expanded its client base and clinical offerings, opened its first Bengaluru clinic, and plans to launch a second facility shortly.

Why This Funding Matters

As longevity care becomes more clinical and data-intensive, Biopeak’s approach signals investor confidence in preventive, AI-led healthcare models. For Indian founders, the takeaway is clear: platforms that blend diagnostics, AI, and longitudinal care are emerging as the next frontier in health-tech.

Keep building. Keep learning. Keep growing with StartupByDoc.

Share.
Leave A Reply